维普中文期刊产品整合服务
268篇 您的检索式:作者名="Kiyota"
    题名 作者 年代 出处 被引量
1Anticorrosion behavior of conversion coatings obtained from unbuffered cerium salts solutions on AA6061-T6显示文摘The anticorrosive properties of cerium based conversion coatings deposited on AA6061-T6 alloy by immersion in unbuffered cerium chloride and cerium nitrate solutions in the presence of hydrogen peroxide were investigated and characterized by potentiodynamic polarization(PDP) and electrochemical impedance spectroscopy(EIS) in 0.5 mol/L NaCl aqueous solution.The microstructure and chemicalcomposition of the protective films were examined by scanning electron microscopy(SEM) and energy dispersive X-ray spectroscopy(EDS).It was found that the best corrosion protection was afforded by the samples treated during 600 s in cerium chloride solution at pH values~5.5-4,showing higher amounts of cerium and polarization resistance values greater than 10 Ω m2.Moreover,an ennoblement of the corrosion potential and decreasing of the cathodic and anodic currents were obtained compared with the cerium nitrate solutions application.Thisbehavior was attributed to the influence of the deposition parameters such as type of the salt anion,i.e.,chelating effect and chaotropic characteristics,pH fluctuations in the conversion solution and deposition time.KIYOTA Sayuri VALDEZ Benjamin STOYTCHEVA Margarita ZLATEV Roumen BASTIDAS Jose Maria 2011Journal of Rare Earths2011,29,10:11
2Comparison of PPIs and H_2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia显示文摘AIM:To compare efficacy of proton pump inhibitors(PPIs)with H2-receptor antagonists(H2RAs)plus prokinetics(Proks)for dysmotility-like symptoms in functional dyspepsia(FD).METHODS:Subjects were randomized to receive openlabel treatment with either rabeprazole 10 mg od(n= 57)or famotidine 10 mg bid plus mosapride 5 mg tid(n=57)for 4 wk.The primary efficacy endpoint was change(%)from baseline in total dysmotility-like dyspepsia symptom score.The secondary efficacy endpoint was patient satisfaction with treatment.RESULTS:The improvement in dysmotility-like dyspep-sia symptom score on day 28 was significantly greater in the rabeprazole group(22.5%±29.2%of baseline) than the famotidine+mosapride group(53.2%± 58.6%of baseline,P<0.0001).The superior benefit of rabeprazole treatment after 28 d was consistent regardless of Helicobacter pylori status.Significantly more subjects in the rabeprazole group were satisfied or very satisfied with treatment on day 28 than in the famotidine+mosapride group(87.7%vs 59.6%,P= 0.0012).Rabeprazole therapy was the only significant predictor of treatment response(P<0.0001),defined as a total symptom score improvement≥50%.CONCLUSION:PPI monotherapy improves dysmotility-like symptoms significantly better than H2RAs plus Proks,and should be the treatment of first choice for Japanese FD.Masahiro Sakaguchi Miyuki Takao Yasuo Ohyama Hiroshi Oka Hiroshi Yamashita Takumi Fukuchi Kiyoshi Ashida Masahiro Murotani Masuyo Murotani Kazuo Majima Hiroshi Morikawa Takashi Hashimoto Keisuke Kiyota Hirohiko Esaki Kanji Amemoto Gouhei Isowa Fumiyuki Takao 2012World Journal of Gastroenterology2012,18,13:8
3Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks显示文摘Yu Kataoka Toru Mukohara Hideo Tomioka Yohei Funakoshi Naomi Kiyota Yutaka Fujiwara Masakazu Yashiro Kosei Hirakawa Midori Hirai Hironobu Minami 2012Investigational New Drugs2012,,:2
4Relationship between C-reactive protein andvis ceral adipose tissue in healthy Japanese subjects显示文摘Saijo Y Kiyota N 2004Diabetes Obes Metab2004,6,4:1
5Revaluation of clinical features of ischemic colitis:analysis of 68 concecutive cases diagnosis by early colonoscopy显示文摘Habu Y Tahashi Y Kiyota K 1996Scand J Gastroenterol1996,31,:1
6Taxane diterpenoids from Taxus yunnanensis and Taxus cuspidate 显示文摘Shi Q W Oritani T Kiyota H 2000Phytochemistry2000,54,8:1
7Japanese guideline for clinical re- search of antimicrobial agents on urogenital infections:The first edi- tion 显示文摘Yasuda M Takahashi S Kiyota H 2011Journal of Infection and Chemotherapy2011,4,23:1
8Foreign technology acquisition policy and firm performance in Japan, 1957 - 1970 : Micro - aspects of industrial policy 显示文摘KIYOTA K OKAZAKI T 2005International Journal of Industrial Organization2005,23,:1
9Exports, FDI and Productivity : Dynamic Evidence from Japanese Firms 显示文摘Kimura F Kiyota K 2006Review of World Economics2006,142,4:1
10Laser flash photolysis studies on the interaction between triplet benzophenone and naphthalate anions electron transfer or triplet energy transter 显示文摘Yamaji M Kiyota T Kimura S 1995Chemistry Physics Letters1995,237,5:1
11Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27 (KIP1) and p15 (INK4B) and induces G1 arrest in oral squamous carcinoma cell lines显示文摘Kiyota A Shintani S Mihara M 2002Oncol2002,63,1:1
12Retroperitoneoscopic ureterolithotomy for impacted ureteral stone 显示文摘Kiyota H Ikemoto I Asano K 2001Int J Urol2001,8,7:1
13Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real time PCR assay and melt curve analysis 显示文摘Mendes RE Kiyota KA Monteiro J 2007J Clin Microbiol2007,45,2:1
14Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones 显示文摘Ishii Y Kiyota H Sakai S 2004Leukemia2004,18,8:1
15Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atheroscle-rosis in ApoE-deficient mice by inhibiting ACAT 显示文摘Yukio Fujiwara Naoko Kiyota Masaharu Hori 2007Arterioscler Thromb Vasc Biol2007,27,11:1
16Physical effects of dust on leaf physiology of cucumber and kidney bean plants 显示文摘HIRANO T KIYOTA M AIGA I 1995Envi- ronmental Pollution1995,89,3:1
17Studies on the Metabolism of the antidiabetic agent pioglitazone, identification of metabolites in rats and dogs显示文摘Kiyota Y Kondo T Maeshiba Y 1997Arzneim Forsch/Drug Res1997,47,1:1
18Preventive effect of tomato sapogenol on atherosclerosis显示文摘Fujiwara Yukiko Kiyota Naoko Matsushita Sayaka 2006Yakugaku Zasshi2006,126,3:1
19Disposition of the antidiabetic agent pioglitazone in rats, dogs, and monkeys 显示文摘Maeshiba Y Kiyota Y Yamashita K 1997Arzneim Forsch/Drug Res1997,47,1:1
20On Weighted Fibonacci and Lucas Sums显示文摘Kiyota Ozeki 2005The Fibonacci Q2005,45,2:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费